Wilson Kemp & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$309K Sell
5,462
-7,472
-58% -$420K 2.82% 15
2014
Q2
$714K Sell
12,934
-14,435
-53% -$787K 2.56% 10
2014
Q1
$1.48M Sell
27,369
-6,995
-20% -$362K 3.85% 6
2013
Q4
$1.64M Sell
34,364
-3,261
-9% -$149K 3.15% 9
2013
Q3
$1.71M Sell
37,625
-37,239
-50% -$1.7M 3.76% 6
2013
Q2
$3.32M Buy
+74,864
New +$3.34M 3.17% 6

Other funds holding MRK

Wilson Kemp & Associates's MRK Position: Q3 2014 in Review

Wilson Kemp & Associates reduced its Merck (MRK) stake by 58% in Q3 2014, selling an estimated $420K and leaving 5,462 shares worth $309K. The position accounts for 2.82% of the portfolio, ranked #15.

Wilson Kemp & Associates first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.32M in Q2 2013. 1,619 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • Wilson Kemp & Associates held 5,462 shares of Merck worth $309K as of Q3 2014.
  • Wilson Kemp & Associates sold 7,472 Merck shares in Q3 2014, an estimated $420K.
  • Merck made up 2.82% of Wilson Kemp & Associates's portfolio in Q3 2014, its #15 holding.
  • Wilson Kemp & Associates first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • Wilson Kemp & Associates's Merck position peaked at $3.32M in Q2 2013.
  • 1,619 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on Wilson Kemp & Associates's 13F filing for Q3 2014, filed 20 Oct 2014.